{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-079773","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.212045+00:00","generated_at":"2026-05-20T04:50:52.802038+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Tenaya Therapeutics shareholders elect all three Class I directors and ratify Deloitte as auditor","bullets":["David Goeddel, Ph.D. elected with 80,444,762 votes for, 8,262,596 withheld.","Jeffrey T. Walsh elected with 70,717,277 for, 17,990,081 withheld.","R. Sanders Williams elected with 70,410,874 for, 18,296,484 withheld.","Ratification of Deloitte & Touche LLP passed with 120,339,858 for, 416,705 against, 192,213 abstain.","Broker non-votes of 32,241,417 on each director nominee; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-079773","json":"https://secwatch.observer/filing/0000950170-25-079773.json","markdown":"https://secwatch.observer/filing/0000950170-25-079773.md","text":"https://secwatch.observer/filing/0000950170-25-079773.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025079773/0000950170-25-079773-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025079773/tnya-20250528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:50:52.802038+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}